Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PINCR: Pazopanib in Non-clear Cell mRCC
NCT01767636Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- May 2013
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in non-clear cell renal cell carcinoma (nccRCC), sponsored by Mayo Clinic. Started May 2013; status: completed.
02
Drugs
pazopanib
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on NCT01767636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767636.